Treatment with inebilizumab is significantly effective and safe for patients with AChR+ or MuSK+ generalized myasthenia ...

ZYN002 is safe and effectively reduces irritability-related behavioral symptoms in children and adolescents with fragile X ...

The use of oral edaravone for a total of 144 weeks is safe and well-tolerated among patients with amyotrophic lateral ...

Women and racial-ethnic minorities remain underrepresented in academic neurology, especially in higher ranks and leadership ...

Neurophobia among Hispanic medical students may deter them from choosing neurology, potentially leading to a future shortage ...

Patients who take foslevodopa/foscarbidopa who wake in the "ON" state show improved motor function, daily activities, and ...

Over the last 2 decades, aspiration pneumonia and Alzheimer disease-related mortality have significantly decreased in older ...

Hypertension-related vascular dementia mortality rates have increased over the past 15 years, especially among Black and ...

Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.

Fremanezumab is safe, effective, and tolerable for children and adolescents with episodic migraine, reducing monthly migraine ...

Early CPAP treatment for individuals with OSA may help reduce the onset of Parkinson disease and other neurodegenerative ...

Two women neurologists reflect on their journeys into the field of neurology and share advice for aspiring women neurologists ...